Activity of the multikinase inhibitor dasatinib against ovarian cancer cells
AUTOR(ES)
Konecny, G E
FONTE
Nature Publishing Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2778533Documentos Relacionados
- Alkylating agents and immunotoxins exert synergistic cytotoxic activity against ovarian cancer cells. Mechanism of action.
- Pseudomonas exotoxin coupled to a monoclonal antibody against ovarian cancer inhibits the growth of human ovarian cancer cells in a mouse model.
- Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells
- Characterization of immunotoxins active against ovarian cancer cell lines.
- A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells